Daly James M insider trades
Daly James M has filed 28 Form 4s with the SEC that we hold, for Madrigal Pharmaceuticals, INC. (MDGL) (Director), Acadia Pharmaceuticals INC (ACAD) (Director), BLCM (Director) and Cytokinetics INC (CYTK) (Director), among 5 companies in all. Across all of them we count 0 purchases worth $0 and 22 sales worth $15.1M reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($671.1K). The largest single trade was a sale of 14,302 shares of Madrigal Pharmaceuticals, INC. worth $5.0M, dated 2025-02-27. The first filing on our record is dated 2021-07-06 and the latest 2026-10-02.
Madrigal Pharmaceuticals, INC. (MDGL)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-04-01 | S, sale reported on Form 4 | 6,809 | $1.7M | 2024-04-03 |
| 2024-04-01 | S, sale reported on Form 4 | 7,401 | $1.9M | 2024-04-03 |
| 2024-04-01 | S, sale reported on Form 4 | 3,604 | $927.3K | 2024-04-03 |
| 2024-04-01 | S, sale reported on Form 4 | 1,460 | $377.1K | 2024-04-03 |
| 2024-04-01 | S, sale reported on Form 4 | 200 | $51.8K | 2024-04-03 |
| 2024-04-01 | S, sale reported on Form 4 | 800 | $209.6K | 2024-04-03 |
| 2024-04-01 | S, sale reported on Form 4 | 178 | $46.9K | 2024-04-03 |
| 2024-04-01 | S, sale reported on Form 4 | 351 | $93.0K | 2024-04-03 |
| 2024-04-01 | S, sale reported on Form 4 | 500 | $132.7K | 2024-04-03 |
| 2024-04-01 | S, sale reported on Form 4 | 274 | $73.1K | 2024-04-03 |
| 2024-04-02 | S, sale reported on Form 4 | 200 | $49.7K | 2024-04-03 |
| 2024-04-02 | S, sale reported on Form 4 | 842 | $204.8K | 2024-04-03 |
| 2024-04-02 | S, sale reported on Form 4 | 6,279 | $1.5M | 2024-04-03 |
| 2024-04-02 | S, sale reported on Form 4 | 2,991 | $732.5K | 2024-04-03 |
| 2024-04-02 | S, sale reported on Form 4 | 557 | $137.2K | 2024-04-03 |
| 2024-04-02 | S, sale reported on Form 4 | 43 | $10.6K | 2024-04-03 |
| 2025-02-27 | S, sale reported on Form 4 | 770 | $268.7K | 2025-02-28 |
| 2025-02-27 | S, sale reported on Form 4 | 14,302 | $5.0M | 2025-02-28 |
| 2025-02-27 | S, sale reported on Form 4 | 398 | $138.1K | 2025-02-28 |
Acadia Pharmaceuticals INC (ACAD)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-11-10 | S, sale reported on Form 4 | 30,000 | $671.1K | 2025-11-12 |
BLCM
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Cytokinetics INC (CYTK)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Halozyme Therapeutics, INC. (HALO)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-08-11 | S, sale reported on Form 4 | 10,000 | $437.1K | 2023-08-15 |
| 2023-08-14 | S, sale reported on Form 4 | 10,000 | $437.4K | 2023-08-15 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1560782) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms